On 4/20/2017, Shares of Marvell Technology Group Ltd. (NASDAQ:MRVL) closed at $14.94 in last trading day. After noting the initial trading entry at $14.96, it reached to a day’s high of $15.01 and moved to a day’s low of $14.74. The recent daily volume was 4.63 million as contrast to it’s an average volume of 6.1 million.
The last close of the Marvell Technology Group Ltd. stock reflects that it traded -3.93% from its 50-day moving average of $15.55. The stock traded above +2.74% to its 200-day MA of $14.54. Furthermore, it moved lower -10.65% from its 52-week high of $16.72 and +65.08% up from $9.05, which is 52-week low of the stock.
Marvell Technology Group Ltd.’s (MRVL) moved with shift of 0.88% in the past week. Over the last three months, the shares of the company have changed 6.37% and performed 15.77% over the last six months. The stock currently has Monthly Volatility of 1.88% and Weekly Volatility of 1.78%.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) finalized the last transaction at value of $51.51, with a daily change of -0.77% or -0.40 points. The company maintained volume of 1.31 million shares. In past trading day, the stock hit the maximum price of $52.83 and touched to minimum value of $51.36. It has a market cap of $ 4.49B.
As of last trade close, the stock is trading downside -6.60% from its one year high of $55.15 and moved +37.93% upward from $37.35, which is one year low of the stock.
The stock traded above +14.93% from its 50-day moving average of $44.82. Furthermore, the stock moved up +16.28% to its 200-day MA of $ 44.30.
During the last month, Neurocrine Biosciences, Inc.’s (NBIX) has changed 23.32% and performed 15.52% over the last 6 months. The mean rating score for this stock is at 1.70. This rating scale contains from 1 to 5 with 5 representing a Strong Sell, 1 signifying a Strong Buy and 3 demonstrating a Hold. The Volatility was noted at 4.17% in recent month and observed Weekly Volatility of 4.16%.